A Three-Month Non-Interventional Study of Asthma Treatment with Budesonide/Formoterol / 中国呼吸与危重监护杂志
Xin ZHOU; Jianguo HONG; Jianbao XIN; Changgui WU; Jianping BO; Tiantuo ZHANG; Changzheng WANG; Shaoxi CAI; Chan LIU; Chea QIU; Jianan HUANG; Guoxiang LAI; Lingfei KONG; Chuntao LIU; Zhaang MA; Kewu HUANG; Heping FANG; Jianying ZHOU; Zhuochang CHENG; Peizong SUN; Genyun SUN; Libo WANG; Suping TANG; Zhimia CHEN; Changchong LI; Deyu ZHAO; Rongjun LIN; Yuefie ZHENG; Li XIANG; Xiaoqing ZHOU; Yuzhi CHENG.
Chinese Journal of Respiratory and Critical Care Medicine
; (6): 341-344, 2009.
Artículo
en Zh
| WPRIM | ID: wpr-406430
Objective To evaluate the efficacy of Budesonide/formoterol to control asthma under real-life conditions.Methods A muhi-center, open label, non-interventional study was conducted.Asthma control after 12 week therapy with Budesonide/formoterol was assessed by Asthma Control Questionnaire (ACQ) and modified Asthma Control Questionnaire (ACQ5).Results A total of 360 asthma patients were recruited,including 228 adult patients and 132 child patients.After 12 weeks' therapy,all the patients' medium value of ACQ was decreased significantly from 2.03 (adults 2.20, children 1.74) at baseline to 0.60 (adults 0.78, children 0.29) (P < 0.0001), and the medium value of ACQ5 was also decreased significantly from 2.4 (adults 2.24, children 1.76) at baseline to 0.47 (adults 0.62, children 0.20) (P < 0.0001).Conclusion Budesonide/formoterol is effective in asthma treatment, by which most asthma patients obtain and maintain clineal control.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados